Dr. Olivia stepped down from his post last June after health insurer Highmark announced its plans to acquire WPAHS, which are pending regulatory approval.
Retirement and other deferred compensation comprised $5.4 million of the $7.4 million total, according to the report. Dr. Olivia’s 2011 severance was also listed under the deferred payment category. The remaining compensation went toward his base salary, bonuses, incentives, and other compensation and nontaxable benefits.
Dr. Olivia has since been working as a consultant for Highmark, but that arrangement will end this summer.
More Articles on Hospital Executive Compensation:
18 Connecticut Hospital Execs Make More Than $1M
6 For-Profit Hospital Chain Executives Who Received 2012 Base Salary Raises
California Bill Would Restrict Pay of Hospital District Executives
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
